High-dose immunoglobulin therapy in renal transplant recipients with hemophagocytic histiocytic syndrome

Asci G. , Toz H. , Ozkahya M. , CAGIRGAN S., Duman S. , SEZIS M., ...Daha Fazla

JOURNAL OF NEPHROLOGY, cilt.19, ss.322-326, 2006 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 19 Konu: 3
  • Basım Tarihi: 2006
  • Sayfa Sayıları: ss.322-326


Background: Hemophagocytic histiocytic syndrome (HHS) generally occurs in immunocompromised patients and often has a rapidly fatal course. HHS may be cured by treatment of the underlying disorder, especially when it is triggered by an infection. If no cause has been found, no therapy is known and outcome is poor. The aim of this study was to investigate the clinical course and response to intravenous immunoglobulin treatment in renal transplant patients diagnosed with HHS.